Association of Cannabis Use With Cigarette Use in People Certified for Medical Cannabis for Chronic Pain: A Secondary Analysis of a Prospective Cohort Study

Background: Chronic pain is associated with cigarette use and cannabis use and people with chronic pain report using each to manage pain. Little is known about how medical cannabis legalization impacts cigarette use among people with chronic pain. We aimed to examine the relationship between cannabis use and cigarette use in New York State. Methods: Secondary analysis of a prospective, longitudinal cohort study of adults with chronic pain, using opioids and newly certified to use medical cannabis. Quarterly questionnaires over 9 months collected self-reported cannabis use, cigarette use, pain, anxiety and depression. The primary outcome was past 30-day cigarette use [yes/no] and cigarettes per day [CPD]. Four two-step mixed-effect models assessed the longitudinal impact of cannabis on cigarette use. Independent variables for each were cannabis use days in the past 30 days of: (1) any cannabis; (2) cannabis by source (unregulated, medical, mixed); (3) cannabis by route (inhaled, non-inhaled); (4) added interaction between cannabis use and pain severity. Results: Of 223 participants, 75 (33.6%) used cigarettes and 164 (73.5%) used cannabis at baseline. In Model 1, any cannabis use was not significantly associated with cigarette use or CPD. In Model 2, days of unregulated cannabis use (β = .058, P = .002) and mixed cannabis use were associated with CPD (β = .041, P = .018). In Model 3, non-inhaled cannabis use was negatively associated with CPD (β = −.015, P = .015). In Model 4, the interaction term between any cannabis use and pain intensity was significant (β = −.006; P = .047). The association between cannabis use and CPD was positive at pain severity scores less than 6.73, but above it, cannabis use was negatively associated with CPD. Conclusion: Unregulated and non-inhaled cannabis use were implicated in the association between cannabis use and cigarette use, and pain severity moderated the effect of cannabis use on CPD. Further studies are needed to fully understand this relationship.

Authors

Institutions

Publication Details

Journal
Substance Use &amp Addiction Journal
Published
2026-10-13
DOI
https://doi.org/10.1177/29767342261489466
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Cannabis Use With Cigarette Use in People Certified for Medical Cannabis for Chronic Pain: A Secondary Analysis of a Prospective Cohort Study

Chinazo O. Cunningham, Joanna L. Starrels, Deepika E. Slawek, Julia Hope Arnsten et al.
Substance Use &amp Addiction Journal
Cannabis and Cannabinoid Research
article

Association of Cannabis Use With Cigarette Use in People Certified for Medical Cannabis for Chronic Pain: A Secondary Analysis of a Prospective Cohort Study

Chinazo O. Cunningham, Joanna L. Starrels, Deepika E. Slawek, Julia Hope Arnsten, Shadi Nahvi, Chenshu Zhang, FRANCES RUDNICK LEVIN, Gayatri Nangia, Giovanna Calderon DiFrancesca, Nancy Sohler, Haruka Minami
article en

Abstract

Background: Chronic pain is associated with cigarette use and cannabis use and people with chronic pain report using each to manage pain. Little is known about how medical cannabis legalization impacts cigarette use among people with chronic pain. We aimed to examine the relationship between cannabis use and cigarette use in New York State. Methods: Secondary analysis of a prospective, longitudinal cohort study of adults with chronic pain, using opioids and newly certified to use medical cannabis. Quarterly questionnaires over 9 months collected self-reported cannabis use, cigarette use, pain, anxiety and depression. The primary outcome was past 30-day cigarette use [yes/no] and cigarettes per day [CPD]. Four two-step mixed-effect models assessed the longitudinal impact of cannabis on cigarette use. Independent variables for each were cannabis use days in the past 30 days of: (1) any cannabis; (2) cannabis by source (unregulated, medical, mixed); (3) cannabis by route (inhaled, non-inhaled); (4) added interaction between cannabis use and pain severity. Results: Of 223 participants, 75 (33.6%) used cigarettes and 164 (73.5%) used cannabis at baseline. In Model 1, any cannabis use was not significantly associated with cigarette use or CPD. In Model 2, days of unregulated cannabis use (β = .058, P = .002) and mixed cannabis use were associated with CPD (β = .041, P = .018). In Model 3, non-inhaled cannabis use was negatively associated with CPD (β = −.015, P = .015). In Model 4, the interaction term between any cannabis use and pain intensity was significant (β = −.006; P = .047). The association between cannabis use and CPD was positive at pain severity scores less than 6.73, but above it, cannabis use was negatively associated with CPD. Conclusion: Unregulated and non-inhaled cannabis use were implicated in the association between cannabis use and cigarette use, and pain severity moderated the effect of cannabis use on CPD. Further studies are needed to fully understand this relationship.

Substance Use &amp Addiction Journal
Albert Einstein College of Medicine (US), Montefiore Medical Center (US), Fordham University (US), New York State Office of Mental Health (US), New York State Psychiatric Institute, Columbia University (US)
National Institute of Health Sciences, National Institute on Drug Abuse
Openalex Percentile: Top 14%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.